
Keywords: uPA، فعال کننده ی پلاسمینوژن نوع یروکیناز; ACR; American College of Rheumatology; ANA; antinuclear antibody; CHB; congenital heart block; CRP; C-reactive protein; GPI; glycosyl phosphatidylinositol; ECM; extracellular matrix; eGFR; estimated glomerular filtration; FSGS; focal segmental glomerulosc